Adamis Pharmaceuticals Corporation (ADMP) has an overall financial health rating of B- with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2023-10-03.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2023-10-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-25 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-21 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-18 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-11 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-07 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-09-01 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2023-08-31 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
